Clinical trial
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With Presbyopia
NCT04675151 is registered in ClinicalTrials.gov with Ocuphire Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With Presbyopia
- Lead sponsor
- Ocuphire Pharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 15, 2021
- Completion date
- June 30, 2021
- Enrollment
- 150 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.